Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up

Acta Ophthalmologica

Volumn 93, Issue 1, 2015, Pages e1-e6

  Arcieri, Enyr S ^a,b,c   Paula, Jayter S ^d   Jorge, Rodrigo ^d   Barella, Kleyton A ^a   Arcieri, Rafael S ^d   Secches, Danilo J ^d   Costa, Vital P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Presidente Antônio Carlos University UNIPAC   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

bevacizumab; glaucoma; glaucoma drainage implants; intraocular pressure; neovascular

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; STEROID; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AHMED GLAUCOMA VALVE IMPLANTATION; ANTERIOR EYE CHAMBER; ARTICLE; BIOMICROSCOPY; CENTRAL RETINA VEIN OCCLUSION; CHOROIDAL EFFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; FEMALE; GONIOSCOPY; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; INTRAOCULAR TUMOR; LASER COAGULATION; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROSTHESIS IMPLANTATION; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; UVEITIS; VISCOELASTICITY; VISUAL ACUITY; VISUAL PROSTHESIS; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA, NEOVASCULAR; INTRAVITREAL DRUG ADMINISTRATION; IRIS; TREATMENT OUTCOME; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTERIOR CHAMBER; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; IRIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84932147534     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12493     Document Type: Article

References (27)

1. Allingham RA, Damji KF, Freedman S, Moroi S, &, Shafranov G, (eds). (2005): Glaucomas associated with disorders of the retina, vitreous and choroids. In: Shields' textbook of glaucoma, 5th edn. Philadelphia: Lippincott, Williams & Wilkins 328-346.
2. Avery RL, Pieramici DJ, Rabena MD, et al. (2006): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-372.
3. Batioglu F, Astam N, &, Ozmert E, (2008): Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol 28: 59-61.
4. Beutel J, Peters S, Luke M, et al. (2010): Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 88: 103-109.
5. Casey R, &, Li WW, (1997): Factors controlling ocular angiogenesis. Am J Ophthalmol 124: 521-529.
6. Casson RJ, (2006): Refractory glaucoma-here there be dragons. Clin Exp Ophthalmol 34: 732-733.
7. Costagliola C, Cipollone U, Rinaldi M, et al. (2008): Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol 66: 667-673.
8. Ehlers JP, Spirn MJ, Lam A, et al. (2008): Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 28: 696-702.
9. Eid TM, Radwan A, el-Manawy W, et al. (2009): Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol 44: 451-456.
10. Hayreh SS, (2007): Neovascular glaucoma. Prog Retin Eye Res 26: 470-485.
11. Kang JY, Nam KY, Lee SJ, et al. (2013): The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma. Int Ophthalmol Nov 2 [Epub ahead of print].
12. Kjeka O, Jansson RW, Bredrup C, et al. (2013): Early panretinal photocoagulation for ERG-verified ischaemic central retinal vein occlusion. Acta Ophthalmol 91: 37-41.
13. Mahdy RA, Nada WM, Fawzy KM, et al. (2012): Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by ahmed valve implantation in neovascular glaucoma. J Glaucoma 22: 768-772.
14. Martínez-Carpio PA, Bonafonte-Márquez E, Heredia-García CD, et al. (2008): Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review. Arch Soc Esp Oftalmol 83: 579-588.
15. Moraczewski AL, Lee RK, Palmberg PF, et al. (2009): Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol 93: 589-593.
16. Sevim MS, Buttanri IB, Kugu S, et al. (2013): Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma. Ophthalmologica 229: 94-100.
17. Simha A, Braganza A, Abraham L, et al. (2013): Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev 10: Art No: CD007920.
18. Sivak-Callcott JA, O'Day DM, Gass JD, et al. (2001): Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 108: 1767-1776.
19. Sone H, Okuda Y, Kawakami Y, et al. (1996): Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated (Letter). Diabetes Care 19: 1306-1307.
20. Sothornwit N, (2008): Intravitrealbevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report. J Med Assoc Thai 91 (Suppl 1): 62-65.
21. Tripathi RC, Li J, Tripathi BJ, et al. (1998): Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105: 232-237.
22. Vatavuk Z, Bencic G, &, Mandic Z, (2007): Intravitrealbevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 17: 269-271.
23. Wakabayashi T, Oshima Y, Sakaguchi H, et al. (2008): Intravitrealbevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115: 1571-1580.
24. Yalvac IS, Eksioglu U, Satana B, et al. (2007): Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 21: 65-70.
25. Yang JY, Kim JH, Kim NR, et al. (2012): Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma 21: 331-336.
26. Yazdani S, Hendi K, Pakravan M, et al. (2009): Intravitrealbevacizumab for neovascular glaucoma: a randomized controlled trial. J Glaucoma 18: 632-637.
27. Zhou MW, Wang W, Huang WB, et al. (2013): Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J 126: 1412-1417.